| 1 |
34074182 | Real world use of FLT3 inhibitors for treatment of FLT3+ acute myeloid leukemia (AML): A single center, propensity-score matched, retrospective cohort study. | 2021 Jun 1 |
1 |
| 2 |
34169421 | All-trans Retinoic Acid, Arsenic Trioxide, and Anthracycline-based Chemotherapy Improves Outcome in Newly Diagnosed Acute Promyelocytic Leukemia Regardless of FLT3-ITD Mutation Status. | 2021 Jun |
1 |
| 3 |
31892587 | The Role of Anthracyclines in Acute Myeloid Leukemia Consolidation. | 2020 Jan |
1 |
| 4 |
31069015 | Evaluation of gilteritinib in combination with chemotherapy in preclinical models of FLT3-ITD+ acute myeloid leukemia. | 2019 Apr 2 |
2 |
| 5 |
29139135 | Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemia. | 2018 Feb |
1 |
| 6 |
29544132 | Comparison of anthracyclines used for induction chemotherapy in patients with FLT3-ITD-mutated acute myeloid leukemia. | 2018 May |
1 |
| 7 |
24981688 | Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study. | 2014 Dec |
3 |
| 8 |
21685470 | Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy. | 2011 Oct |
3 |
| 9 |
16982329 | Constitutive c-jun N-terminal kinase activity in acute myeloid leukemia derives from Flt3 and affects survival and proliferation. | 2006 Oct |
1 |